STAT3 and cancer: Consequently, clinical trials testing the anti-cancer effects of atovaquone are currently in progress for STAT3-driven cancers, including ovarian cancer (ClinicalTrials.gov NCT05998135) and AML (ClinicalTrials.gov NCT03568994).